Kinarus is privately funded by a broad base of investors that include current and former Senior Executives from the Life Sciences, Biotech and Pharma industries. Kinarus has been able to effectively leverage this deep expertise to effectively drive its clinical programs and business strategy.
If you are interested in more information and you are a professional or institutional investors in the sense of the FinSA please click the checkbox below:
*The information shown herein is for information purposes only and does not, and is not intended to, constitute a prospectus in the sense of the FinSA or contain an offer or invitation to invest in Kinarus in any jurisdiction where such offer or investment is not permitted. No prospectus in the sense of the FinSA will be prepared for or in connection with the offering of the share in Kinarus in the ongoing Series B financing round on the basis that Kinarus is exempt from such obligation because the shares are not offered to any investors other than professional or institutional investors in the sense of the FinSA and the shares in Kinarus will not be admitted to trading on any trading venue (exchange or multilateral trading facility) in Switzerland.